HILYSENS II is based on the 2-year Hilysens (www.hilysens.eu) research and development project funded by the 'Research for the Benefit of SMEs' program of the European Commission's Seventh Framework Programme (FP7).
HILYSENS II proposes Demonstration Activities for the prototype Lab-on-a- Chip developed during the successful Hilysens research and development project.
This Lab-on-a- Chip prototype (now called the 'Lyme card') was designed as a specific and sensitive diagnostic system for acute, chronic and autoimmunity-associated Lyme disease.
In parallel, a dedicated reader for the Lyme Card (the 'Reader') was developed, together with customized software to enable diagnosis of Borrelia infections.
The previous Hilysens project constituted a multidisciplinary and transnational approach including molecular biology, material physics, optical and electronic engineering and medicine. It managed to assemble a consortium of outstanding scientific and technological experts from academia and industry to perform the RTD tasks and to ensure the development of a cutting-edge diagnostic technology and SMEs from different fields interested in exploiting the final product as well as some of the individual technologies developed.
The product "lead user" SMEs, MLD in the microfluidic chip production sector and MICRO BIO from the in-vitro diagnostics instrumentation area played major roles in the previous project and will now participate in bringing the prototype diagnostic tool to the market.
Along with these companies, the end-users (STAB, and BCA and UGOT: clinical laboratory and hospitals, respectively) will also play key roles in testing the prototype and disseminating the results to potential clients and to regulatory bodies.